Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07893106) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight' on Oct. 19.

Brief Summary: This is a randomized, placebo-controlled, double-blind, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of ASC36 Tablets for Oral Use in Adult Participants with Obesity or Overweight

Study Start Date: Oct. 13

Study Type: INTERVENTIONAL

Condition: Chronic Weight Management

Intervention: DRUG: ASC36 tablets, for oral use

ASC36 tablets are an investigational ...